Raphael Townshend

Raphael Townshend is the founder and CEO of Atomic AI, where he oversees the development of AI technologies for synthetic biology and drug discovery, focusing on RNA modeling. He earned a PhD in Computer Science from Stanford University, with expertise in machine learning applications to biological problems. Townshend has done research on AI-driven protein and RNA design, including publications in journals. He founded Atomic AI in 2021 and secured venture funding for the company's biotech initiatives. His primary expertise areas are AI, machine learning, and computational biology.